Table 4.
Haplotype frequency in the study population in both affected and unaffected subjects
| P2X7, Gly150Arg | P2X4, Tyr315Cys | Population frequency | Affected frequency | Unaffected frequency | OR | 95 % CI | p-Value | Number | |
|---|---|---|---|---|---|---|---|---|---|
| H11a | G | A | 97.4 | 95.5 | 98.2 | 0.44 | (0.24–0.81) | 0.008 | 867 |
| H12b | A | A | 1.3 | 2.1 | 0.88 | 2.08 | (0.89–4.85) | 0.090 | 22 |
| H13c | G | G | 0.8 | 1.4 | 0.56 | 2.44 | (0.84–7.13) | 0.103 | 15 |
| H14d | A | G | 0.5 | 0.88 | 0.31 | 2.60 | (0.64–10.50) | 0.18 | 9 |
Furthermore, the table shows the osteoporosis risk for each haplotype compared to all other haplotypes and their osteoporosis risk
OR odds ratio; CI confidence interval
aWild-type
bH12: Arg150-Tyr315
cH13: Gly150-Cys315
dH14: Arg150-Cys315